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ABSTRACT
Background: In the year 2020 we observe the world adapting to „new normal“ due to the 
COVID-19 pandemic, ways of which include physical distancing, hand hygiene, and wearing 
a face mask. There is no conclusive evidence about ocular manifestations of the new coro-
navirus infection, but cases of conjunctivitis, keratitis, and episcleritis have been reported 
in infected individuals. Objective: Determining if wearing a face mask during COVID-19 
pandemic causes a new onset or deterioration of previously existing dry eye disease (DED). 
Methods: A prospective cohort study included 203 participants, all using surgical face-
masks daily due to new regulations during COVID-19 pandemic. Participants completed a 
survey, containing modified Ocular Surface Disease Index (OSDI) questionnaire. They were 
divided into groups according to: sex, age, duration of face mask-wear, and existence of 
prior DED history. Results: Our results indicate that women have a statistically higher OSDI 
score compared to men (14.4 (IQR = 2.4 – 41.7) vs. 5.0 (IQR = 0.0 – 24.4); P = .004). Age 
did not significantly affect OSDI median values. Group that used masks from 3 to 6 hours/
day demonstrated significantly higher OSDI scores compared to <3 hour/day group (15.3 
(IQR = 8.3 – 47.7) vs. 8.3 (IQR = 0.0 – 35.1); P = .001). OSDI score was significantly greater 
in participants with prior DED history compared to those without it (36.1 (IQR = 14.1 – 61.6) 
vs. 4.2 (IQR = 2.3 – 8.3); P <.001). Participants with prior DED exhibited greater worsening 
of their disturbances during mask wearing period compared to the ones without previous 
DED (54.8% vs. 17.7%, Chi-Square 28.3 DF1; P <.001), regardless of daily mask wear dura-
tion. Conclusion: Our study confirmed the existence of mask-associated dry eye (MADE), 
most profoundly in females, subjects with a history of prior DED, and if wearing a face 
mask lasts longer than 3 hours per day. Ophthalmologists should advise their patients of 
the potential ocular surface health risks related to inadequately fitted facemasks.
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1. BACKGROUND
During December 2019, Wuhan, Hubei province, China, became the cen-
ter of an outbreak for the pneumonia of unknown cause, raising profound 
international attention. By January 2020, Chinese scientists had isolated a ge-
netic sequence of the 2019 novel coronavirus (SARS‐CoV‐2). Widely report-
ed as the COVID-19 (coronavirus disease), this respiratory tract infection 
had spread from Wuhan China to the rest of the world consequently causing 
a global pandemic. In the year 2020 we observe the world adapting to „new 
normal“ due to the COVID-19 pandemic, ways of which include physical dis-
tancing, hand hygiene, and wearing a face mask (1).
There is no conclusive evidence about ocular manifestations of the new 
coronavirus infection, but cases of conjunctivitis, keratitis, and episcleritis 
have been reported in infected individuals (2-5).
Xia and authors detected SARS-CoV-2 virus from tear and conjunctival 
secretion samples in one out of thirty enrolled infected patients (6). Although 
SARS-CoV-2 is not commonly present in tears, ocular manifestations, in-
cluding dry eye disease (DED), are relatively common among COVID-19 
patients and could appear prior to the onset of respiratory symptoms (7, 8).
Different outlooks on the COVID-19 pandemic raised questions about 
facemasks’ usefulness in protection from the virus, but the World Health 
Organization, nevertheless, strongly recommends wearing them. Regardless 
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of the face mask type–from fabric to surgical mask and 
respirator face piece, they are all beneficial in compari-
son to not wearing one (9). Although different types of 
facemasks are used in the general population, they all 
have one thing in common: decreasing the influence of 
infected individuals from spreading the disease and pro-
tecting healthy population from the infection. Studies 
have demonstrated that physical distancing of 1 m or 
more, as well as optimal use of eye protection and face-
masks in public and health-care settings diminish the 
risk from COVID-19 infection by reducing the spread 
of contaminated saliva and droplets from infected indi-
viduals (10).
We have noticed an increased number of patients with 
dry eye symptoms coming to our clinic upon starting to 
wear a face mask during this pandemic outbreak. There-
fore, we have investigated if face mask wear could cause 
eye irritation or worsening of DED symptoms.
Tear Film and Ocular Surface Dry Eye Workshop II 
(TFOS DEWS II) report defines DED as a multifacto-
rial disease of the ocular surface characterized by a loss 
of homeostasis of the tear film, accompanied by ocular 
symptoms, in which tear film instability and hyperos-
molarity, ocular surface inflammation and damage, and 
neurosensory abnormalities play etiological roles (11).
DED leads to a variety of symptoms, including ocu-
lar pain, dryness, itching, and foreign body sensation 
(12). Evaluation of subjective symptoms of DED using 
patient-reported outcome questionnaires (with Ocular 
Surface Disease Index being the most often used), in ad-
dition to clinical findings, is beneficial in accurate DED 
assessment (13).
Current data on mask-associated DED symptoms is 
very limited. Rare reports on this issue include com-
mentary of patients complaining about DED symptoms 
worsening while using a face mask (14), and a letter to 
the editor describing a survey on healthy medical stu-
dents (15).
Potential reason was described by Giannaccare et al. 
who have discussed mechanisms that could contribute 
to the onset or increase in DED symptoms during the 
use of face masks. They stated that a displacement or 
incorrect fitting of the face mask could disperse the air 
around the eyes and potentially cause rapid tears’ evap-
oration. The authors have found worsening of ocular 
discomfort symptoms in 10.3%, and the need for daily 
use of ocular lubricants in 19.6% of survey participants 
(15). A recent case report illustrated an additional risk 
of post-operative MADE after cataract surgery under 
topical anesthesia due to a poorly fitted facemask (16). 
Similar mechanism was described in a study by Hayirci 
and authors in the setting of continuous positive airway 
pressure users (17).
2. OBJECTIVE
The aim of this study was to determining if wearing 
a face mask during COVID-19 pandemic causes a new 
onset or deterioration of previously existing dry eye dis-
ease (DED).
3. PATIENTS AND METhODS
This research was reviewed by an independent Ethical 
review board and conforms with the principles and ap-
plicable guidelines for the protection of human subjects 
in biomedical research. This prospective cohort study 
included 203 participants that were randomly selected 
among patients who were attending the Ophthalmolo-
gy Department of the University Hospital Center Sestre 
milosrdnice (Zagreb, Croatia) during October 2020. All 
participants wore surgical facemasks during the day. A 
consent form was signed after detailed information was 
provided to the subjects. Study followed the tenets of 
the Declaration of Helsinki. Participants were provid-
ed with a survey, containing modified Ocular Surface 
Disease Index (OSDI) questionnaire (18), with an aim 
of determining the existence of DED symptoms or de-
terioration of previous ones, if present, after wearing a 
face mask during COVID-19 pandemic. Original OSDI 
questionnaire was modified by adding “while wearing a 
facemask” to the ending of each question (eg Have you 
experienced any of the following during the last week 
while wearing a facemask). We also added three YES/
NO questions and one regarding the duration of face 
masks-wear to our survey:
• Did you have any dry eye symptoms (pain, irrita-
tion, redness, discomfort...) before you have start-
ed to wear a face mask?
• If YES, have you used artificial tears or any other 
lubricant therapy for relieving dry eye symptoms, 
before you have started to wear a face mask?
• Have you noticed the occurrence/worsening of 
dry eye symptoms after initiation of face mask-
wear?
• How many hours per day do you wear a face mask?
Study participants filled the surveys by themselves 
or with investigators’ aid if needed (in elderly subjects). 
They were divided in groups according to: sex (male/fe-
male), age (younger than 40, 41-60, and older than 60 
years of age), duration of face mask-wear (less than 3, 
from 3 to 6, over 6 hours per day), and existence of prior 
DED history. OSDI index was calculated according to 
the formula OSDI = (sum of scores) x 25 / (number of 
questions answered) (18).
Statistical analysis
Neither OSDI score or the patients age were normally 
distributed according to the Kolmogorov-Smirnov test 
thus non-parametric tests were used; Mann-Whitney 
test when comparing two groups, Kruskal-Wallis test 
when comparing more than two groups. Chi square test 
was used for comparing categorical variables. All statis-
tical analysis was done in Medcalc (19).
4. RESULTS
Study included 203 participants with a mean age of 
47.4 years, among which 70.9% (144) were women. Our 
results indicate that women have a statistically higher 
OSDI score compared to men (14.4 (IQR = 2.4 – 41.7) 
vs. 5.0 (IQR = 0.0 – 24.4); Mann-Whitney P = .004) (Fig-
ure 1).
Mask-Associated Dry Eye During COVID-19 Pandemic
146 ORIGINAL PAPER | MED ARCh. 2021 APR; 75(2): 144-148
All participants were divided into three groups ac-
cording to age: younger than 40 years (43.3%), from 40 
to 60 years (29.1%), and over 60 years of age (27.6%). 
OSDI median values do not show significant difference 
between these three age groups (11.9 (IQR = 0.00 – 
32.6), 10.0 (IQR = 2.1 – 22.1) and 15.8 (IQR = 2.3 – 60.7), 
Kruskal-Wallis P = .077), although the highest average 
OSDI score was found in the oldest age group (31.1) 
(Figure 2). We also divided them regarding the duration 
of face masks wear as follows: <3, 3-6 and >6 hours per 
day. Overall, there were some differences among groups 
(Kruskal-Wallis, P = .032). Group that used masks from 
3 to 6 hours/day demonstrated significantly higher OSDI 
scores compared with <3 hours/day group (15.3 (IQR = 
8.3 – 47.7) vs. 8.3 (IQR = 0.0 – 35.1); Mann Whitney P = 
.01) (Figure 3). Wearing a face mask for over 6 hours/day 
did not show a relevant difference in OSDI compared to 
other groups.
Out of 203 participants, 73 (35.9%) had prior DED 
symptoms. Their OSDI score was significantly greater 
than of those without previous history of DED (36.1 (IQR 
= 14.1 – 61.6) vs. 4.17 (IQR = 0.0 – 18.7); Mann-Whitney 
P <.001) (Figure 4).
Of 73 participants with prior DED symptoms, 59 
(80.8%) were using local eye lubricant therapy and 14 
(19.2%) did not. We have not found a significant differ-
ence in OSDI scores between these two groups (38.9 
(IQR = 15.4 – 62.5) and 18.3 (IQR = 6.3 – 55.0), respec-
tively; Mann-Whitney P =.015). Subjects who reported 
DED symptoms prior to face mask wear had a signifi-
cantly greater worsening of their disturbances during 
mask wearing period compared to the ones without pre-
vious dry eye history (54.8% vs. 17.7%, Chi-Square 28.3 
DF1; P < .001) (Figure 5). This finding was demonstrat-
ed in all groups with previous DED, regardless of daily 
mask wear duration (Figure 6).
5. DISCUSSION
Our results demonstrate that women have a statisti-
cally higher OSDI score than men, which concurs with 
previously reported papers on DED epidemiology (20, 
21). The highest average OSDI score was found in the 
group over 60 years of age, but there was no significant 
Figure 1. OSDI score differences according to sex. Females had 
significantly higher OSDI score than male group. OSDI – Ocular 
Surface Disease Index, F – female, M – male.
Figure 2. OSDI score differences according to age. There was 
no significant difference of OSDI median values. OSDI – Ocular 
Surface Disease Index.
Figure 3. OSDI score differences due to daily face mask-wearing 
duration. Significantly higher OSDI score was noted in the group 
wearing masks for 3-6 hours/day, compared to 0-3 hour/day 
group. OSDI – Ocular Surface Disease Index.
Figure 4. OSDI score according to previous DED history. Prior 
DED group had significantly higher OSDI score. OSDI – Ocular 
Surface Disease Index, DED- – No previous history of dry eye 
disease, DED+- Existence of previous dry eye disease.
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difference of OSDI median values between different 
age groups. TFOS DEWS II report confirmed that DED 
prevalence increases significantly and shows a linear as-
sociation with age, with a greater increase in signs than 
symptoms per decade (21).
This is the first report which showed that subjects who 
wore a face mask from 3 to 6 hours/day demonstrated 
significantly higher OSDI scores compared to those who 
used the mask less frequently. However, even longer dai-
ly mask-wear duration did not result in a relevant OSDI 
change compared to other groups. This could be due 
to the fact that the >6 hours/day group was comprised 
mostly of younger, healthy individuals, required to wear 
a mask during their work hours.
Subjects with prior DED reported worsening of their 
symptoms during mask-wearing period regardless of 
mask-wearing duration. This finding was not present in 
subjects without previous DED. Although neurosensory 
abnormalities and reduced corneal sensitivity are now 
recognized as common features of DED (11), there are 
also reports of cornea’s neuronal network disruption in 
the direction of hypersensitivity (22).
A recent study by Tagawa et al. demonstrated corneal 
hyperalgesia in DED patients with short tear film break-
up time (23). The fact that the patients with dry eye 
might have higher sensitivity for noticing these symp-
toms could explain the difference between the groups. 
Also, the group with previous DED history is signifi-
cantly older than the one without it which alone could 
account for the distribution of the results in the demon-
strated pattern.
6. CONCLUSION
A history of a prior DED, female sex, as well as wearing 
a face mask longer than 3 hours per day, could contrib-
ute to or worsen DED symptoms during face mask-wear. 
Further studies could investigate different facemasks 
(eg facemask with valve could be beneficial in prevent-
ing MADE due to air blowing in direction of the valve). 
Ophthalmologists should advise their patients of the 
potential risks of inadequately fitted facemasks to their 
ocular surface health.
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